| Long name: |
BMF |
| Antigen: |
BMF |
| Other names: |
Bcl-2-modifying factor, Bcl2 modifying factor, N/A, bcl-2-modifying factor, Bcl-2-modifying factor |
| Gene name: |
BMF, BMF |
| Gene synonims: |
BMF, N/A, BMF |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Human (Homo sapiens) |
| Specificity: |
BMF, This is an antibody designed to detect BMF |
| Purification method: |
Antigen Affinity method, Caprylic Acid Ammonium Sulfate Precipitation, etc, The most common purification methods used in the antibody production are Affinity Chromatography |
| Concentration: |
Enquire us for detailed information on the concentration of this antibody |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
Immunohistochemistry (IHC), Western Blot (WB) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
BMF |
| Short name: |
Anti- BMF Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to Bcl2 modifying factor (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BMF and IDBG-6070 and ENSG00000104081 and 90427, BMF and IDBG-646206 and ENSBTAG00000012180 and 541141, Bmf and IDBG-198160 and ENSMUSG00000040093 and 171543, Plasma membranes, protein binding, this GO :0001669 and acrosomal vesicle and cellular component this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005741 and mitochondrial outer membrane and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006915 and apoptotic process and biological process this GO :0015629 and actin cytoskeleton and cellular component this GO :0016459 and myosin complex and cellular component this GO :0032464 and positive regulation of protein homooli this GO merization and biological process this GO :0043276 and anoikis and biological process this GO :0090200 and positive regulation of release of cytochrome c from mitochondria and biological process this GO :0097193 and intrinsic apoptotic signaling pathway and biological process this GO :1900740 and positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway and biological process this GO :2001234 and negative regulation of apoptotic signaling pathway and biological process this GO :2001235 and positive regulation of apoptotic signaling pathway and biological process this GO :2001244 and positive regulation of intrinsic apoptotic signaling pathway and biological process, this GO :0005515 : protein binding, this GO :0005515 : protein binding, Bcl2 modifying factor |
| Identity: |
24132 |
| Gene: |
BMF |
More about : BMF |
| Long gene name: |
Bcl2 modifying factor |
| Synonyms: |
FLJ00065 |
| Locus: |
15q15, 1 |
| Discovery year: |
2004-01-16 |
| GenBank acession: |
BC060783 |
| Entrez gene record: |
90427 |
| Pubmed identfication: |
11546872 |
| RefSeq identity: |
NM_033503 |
| Classification: |
BCL2 homology region 3 (BH3) only |
| Havana BLAST/BLAT: |
OTTHUMG00000129875 |